Pressmeddelanden
Eisais pressrum hos newsdeskTidigare pressmedelanden
| PRESSMEDDELANDE - 2009-05-15 | |||
| Leva med epilepsi blir till Road Show |  |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2009-04-28 | |||
| NOVEL ONCE DAILY ANTI-EPILEPTIC ZEBINIX® APPROVED IN THE EUROPEAN UNION | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2009-02-09 | |||
| EISAI AND BIAL ANNOUNCE PARTNERSHIP AGREEMENT FOR THE EUROPEAN COMMERCIALISATION OF THE NOVEL ONCE DAILY ANTI-EPILEPTIC ZEBINIX® | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2009-02-19 | |||
| EISAI SET TO BECOME AN EMERGING LEADER IN THE TREATMENT OF EPILEPSY | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2009-01-23 | |||
| Celebriteter tar upp kampen mot okunskapen kring epilepsi - Eisai i samarbete slÄpper ny bok om Epilepsi. | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-12-17 | |||
| FDA Approves LUSEDRA™ (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-12-09 | |||
| Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-10-29 | |||
| HOPE FOR MILD ALZHEIMER’S PATIENTS AS HOUSE OF LORDS REFUSES TO HEAR NICE’S APPEAL | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-08-26 | |||
| MORPHOTEK,® INC. EXPANDS ITS PHASE II TRIAL SITE SELECTIONS IN THE EUROPEAN UNION | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-06-26 | |||
| FDA FILES APPLICATION TO CONVERT ONTAK® (DENILEUKIN DIFTITOX) TO FULL APPROVAL FOR USE IN CUTANEOUS T-CELL LYMPHOMA (CTCL) | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-05-20 | |||
| INOVELON® (RUFINAMIDE) A NEW TREATMENT FOR LENNOX-GASTAUT SYNDROMEREDUCES DROP ATTACKS BY OVER 40% |
|
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-05-16 | |||
| ERIBULIN MESYLATE DEMONSTRATED ANTI-TUMOR ACTIVITY IN HEAVILY PRETREATED PATIENTS WITH ADVANCED BREAST CANCER | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-05-16 | |||
| EISAI’S COMMITMENT TO ONCOLOGY DEMONSTRATED BY CLINICAL DATA TO BE PRESENTED AT ASCO ANNUAL MEETING | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-04-03 | |||
| Eisai to Resume Clinical Study to Evaluate E2012 as a Potential Next Generation Alzheimer's Disease Treatment | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-03-12 | |||
| M’s Science and Eisai Sign Option Agreement for Sigma Agonist SA4503 | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2008-02-15 | |||
| EUROPEAN REGULATORY AGENCY GRANTS ORPHAN STATUS TO MORPHOTEK®’S FARLETUZUMAB™ AND MORAb-009 | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2007-12-18 | |||
| Nu kan man minska antalet droppattacker med 42% hos patienter med Lennox-Gastaut Syndrom tack vare läkemedlet Inovelon | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2007-12-10 | |||
| EISAI TO ACQUIRE MGI PHARMA FOR $41 PER SHARE IN AN ALL CASH TRANSACTION | |
Ladda ner Pressreleasen |
|
| PRESSMEDDELANDE - 2007-12-05 | |||
| Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement with Novel Antibody Treatment for Alzheimer’s Disease | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-12-05 | |||
| Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement with Novel Antibody Treatment for Alzheimer’s Disease | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-12-05 | |||
| BioArctic Neuroscience and Eisai Enter Into Exclusive Licensing Agreement with Novel Antibody Treatment for Alzheimer’s Disease | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-12-04 | |||
| Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement with Novel Antibody Treatment for Alzheimer’s Disease | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-09-24 | |||
| Eisai återtar marknadsrättigheterna av protonpumpshämmaren Pariet i Norden | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-09-12 | |||
| Eisai tecknar avtal om ensamrätt att marknadsföra NeuroBloc i Europa | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-09-10 | |||
| Smärtläkemedlet Prialt ingår nu i läkemedelsförmånen | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-06-18 | |||
| Nytt epilepsiläkemedel för barn | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-06-07 | |||
| Danmark får som første land i verden ny behandlingsmulighed: Nyt lægemiddel til alvorlig form for epilepsi hos børn |
|
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2007-03-26 | |||
| Från tropisk havssnigel till modernt smärtläkemedel | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2006-12-13 | |||
| Nyt websted skal afhjælpe fordomme og tabuer om epilepsi | |
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2006-12-04 | |||
| Ny SIFO-undersökning: Stor okunskap om epilepsi bland allmänheten |
|
Ladda ner Pressreleasen | |
| PRESSMEDDELANDE - 2006-12 | |||
| Ny effektiv epilepsibehandling i Norge | |
Ladda ner Pressreleasen |
|
PRESSMEDDELANDE/UNDERSÖKNING - 2006-12
Stor okunskap om epilepsi bland allmänheten
Ladda ner förkortad version av undersökningen
Ladda ner fullständig version av undersökningen
| PRESSMEDDELANDE - 2006-09-08 | |||
| Eisai Acquires Four Oncology-Related Products from Ligand | |
Ladda ner Pressreleasen |
|
Sidan uppdaterad: 2010-08-30
| Pressmeddelanden | ||
| Här kan du som är journalist läsa aktuella pressmeddelanden | ||
| EISAI I NORDEN Klicka på kartan nedan |
||
| Epilepsiguiden.se | ||
Epilepsiguiden.se - Lär dig mer om epilepsi, dess verkningar och behandlingsmetoder. |
||
| ANDRA WEBBPLATSER | ||
| Eisai Inc. | ||
| Eisai England | ||
| Eisai Japan | ||